Sertaconazole
CAS No. 99592-32-2
Sertaconazole( —— )
Catalog No. M28376 CAS No. 99592-32-2
Sertaconazole is a broad-spectrum antifungal.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 48 | Get Quote |
|
| 10MG | 68 | Get Quote |
|
| 25MG | 115 | Get Quote |
|
| 50MG | 173 | Get Quote |
|
| 100MG | 258 | Get Quote |
|
| 200MG | 388 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSertaconazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionSertaconazole is a broad-spectrum antifungal.
-
DescriptionSertaconazole is a broad-spectrum antifungal.
-
In VitroSertaconazole (0.03-40 μg/mL; 24 h) inhibits 150 strains of yeasts which includes six Candida species with arithmetic mean MIC of 0.77 μg/mL.Sertaconazole (1 μg/mL; 5, 10, 30, 60 min) activates p38 MAP kinase in a time-dependent manner.Sertaconazole (1, 2 μg/mL; 6, 8, or 24 h) increases a twofold release of PGE2 via COX-2 in keratinocytes, which is dependent on p38 activation.Cetaconazole (10, 20, 30, 40 μM; 24 h) induces strong mitotic arrest by depolymerizing interphase and spindle microtubules, thereby inducing chromosome aggregation defects and causing anti-proliferation effect.Sertaconazole (20, 40 μM; 24 h) induces apoptosis through p53 pathway in HeLa cells.Sertaconazole (20, 30 μM; 24, 48, and 72 h) inhibits the migration of HeLa cells in a concentration-dependent manner.Sertaconazole (15, 30 μM; 24 h) induces autophagy in A549, H460 cells. Cell Viability AssayCell Line:C. albicans, C. guilliermondii, C. krusei, C. parapsilosi, C. tropicalis, C. glabrataConcentration:0.03-40 μg/m Incubation Time:24 h Result:Againsted 150 strains of yeasts (six Candida species) which included C. albicans, C. guilliermondii, C. krusei, C. parapsilosi, C. tropicalis, C. glabrata species with arithmetic mean MIC values of 1.02, 0.51, 0.38, 0.31, 1.67 and 0.78 μg/mL, respectively.Western Blot Analysis Cell Line:HaCaT cells Concentration:1 μg/mL Incubation Time:5, 10, 30, 60 min Result:Showed activity of activating p38 MAP kinase and Hsp27 in a time-dependent manner.Western Blot Analysis Cell Line:HaCaT cells Concentration:1, 2 μg/mL Incubation Time:6 or 8 h Result:Induced 50% expression of COX-2 and resulted in a twofold increased in PGE2 release.Western Blot Analysis Cell Line:siRNA-transfected HaCaT cells (without p38 MAP kinase expression)Concentration:1 μg/mL Incubation Time:24 h Result:Mediated induction of PGE2 was dependent on p38 activation.Cell Proliferation Assay Cell Line:HeLa, HEK-293, MCF-7, A549 cells Concentration:0-100 μM Incubation Time:24 h Result:Showed antiproliferation activity with IC50s of 38, 45.1, 41.5, and 40.8 μM for HeLa, HEK-293, A549, and MCF-7 cells, respectively.
-
In VivoSertaconazole (1% (w/v); apply to the left ear, once) suppresses of TPA-induced ear edema CD-1 mice. Animal Model:CD-1 mice (TPA-induced ear edema model).Dosage:1% (w/v)Administration:Apply to the left ear, once.Result:Exhibited a significant reduction of inflammation in mice by mediating PGE2 release.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntifection|Antibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number99592-32-2
-
Formula Weight437.76
-
Molecular FormulaC20H15Cl3N2OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jaiswal R, et al. Totarol inhibits bacterial cytokinesis by perturbing the assembly dynamics of FtsZ. Biochemistry. 2007 Apr 10;46(14):4211-20.
molnova catalog
related products
-
Quinupristin
Quinupristin is a streptogramin antibiotic. Quinupristin blocks peptide bond synthesis to prevent the extension of polypeptide chains and promote the detachment of incomplete protein chains in the bacterial ribosomal subunits [2].
-
LYS228
LYS228 is a novel potent monobactam that shows potent activity against carbapenem-resistant isolates of Enterobacteriaceae with MIC90 of 2 ug/ml.
-
NITD-304
NITD-304 is a novel, orally bioavailable mycobacterial membrane protein Large 3 (MmpL3) inhibitor with MIC of 15 nM against M tuberculosis H37Rv.
Cart
sales@molnova.com